AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,710,061 | $67,074,010 | 1.80% |
| Bellevue Group AG | 4,013,500 | $99,334,125 | 1.60% |
| Eagle Health Investments LP | 267,630 | $6,623,843 | 1.46% |
| ARMISTICE CAPITAL, LLC | 3,324,000 | $82,269,000 | 1.26% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $11,236,500 | 0.61% |
| Frazier Life Sciences Management, L.P. | 292,002 | $7,227,050 | 0.48% |
| ArrowMark Colorado Holdings LLC | 1,573,359 | $38,940,635 | 0.47% |
| Deep Track Capital, LP | 422,247 | $10,450,613 | 0.40% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,750,829 | $68,083,018 | 0.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 24,000 | $593,520 | 0.20% |
| Virtus ETF Advisers LLC | 11,823 | $292,619 | 0.18% |
| PDT Partners, LLC | 46,202 | $1,143,500 | 0.14% |
| Headlands Technologies LLC | 9,037 | $223,666 | 0.11% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 10,010 | $247,748 | 0.10% |
| BNP Paribas Asset Management Holding S.A. | 1,002,403 | $24,809 | 0.08% |
| UBS OCONNOR LLC | 105,221 | $2,604,220 | 0.07% |
| MACQUARIE GROUP LTD | 1,992,022 | $49,303,000 | 0.06% |
| Caligan Partners LP | 4,833 | $119,617 | 0.06% |
| Hudson Bay Capital Management LP | 540,000 | $13,365,000 | 0.05% |
| FIRST TRUST ADVISORS LP | 1,775,167 | $43,935,383 | 0.05% |
External links
This page lists AGIOS PHARMACEUTICALS INC's shareholders in Q3 2023. To view AGIOS PHARMACEUTICALS INC's shareholder history, click here.